Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8
Clinical trial NCT02882217 · COMPLETED
Trial details
- NCT number
- NCT02882217
- Sponsor
- EURRUS Biotech GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2017-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.